Bank of America Corp DE lifted its holdings in shares of Waters Co. (NYSE:WAT – Get Rating) by 2.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 347,839 shares of the medical instruments supplier's stock after acquiring an additional 7,729 shares during the quarter. Bank of America Corp DE owned about 0.58% of Waters worth $107,964,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. MainStreet Investment Advisors LLC lifted its holdings in shares of Waters by 0.7% during the 1st quarter. MainStreet Investment Advisors LLC now owns 4,757 shares of the medical instruments supplier's stock valued at $1,476,000 after acquiring an additional 35 shares in the last quarter. Camden Capital LLC lifted its holdings in Waters by 3.3% in the 4th quarter. Camden Capital LLC now owns 1,122 shares of the medical instruments supplier's stock worth $418,000 after buying an additional 36 shares in the last quarter. FDx Advisors Inc. lifted its holdings in Waters by 5.0% in the 1st quarter. FDx Advisors Inc. now owns 776 shares of the medical instruments supplier's stock worth $241,000 after buying an additional 37 shares in the last quarter. Signaturefd LLC lifted its holdings in Waters by 6.1% in the 1st quarter. Signaturefd LLC now owns 660 shares of the medical instruments supplier's stock worth $205,000 after buying an additional 38 shares in the last quarter. Finally, Massmutual Trust Co. FSB ADV lifted its holdings in Waters by 0.9% in the 1st quarter. Massmutual Trust Co. FSB ADV now owns 4,556 shares of the medical instruments supplier's stock worth $1,414,000 after buying an additional 40 shares in the last quarter. Institutional investors and hedge funds own 88.80% of the company's stock.
Get Waters alerts:Waters Price Performance
Shares of NYSE:WAT opened at $275.50 on Friday. The company has a quick ratio of 1.55, a current ratio of 2.10 and a debt-to-equity ratio of 3.66. Waters Co. has a fifty-two week low of $270.36 and a fifty-two week high of $399.81. The firm has a 50-day simple moving average of $319.36 and a 200 day simple moving average of $320.70. The company has a market cap of $16.50 billion, a PE ratio of 24.04, a P/E/G ratio of 3.05 and a beta of 0.87.
Waters (NYSE:WAT – Get Rating) last announced its quarterly earnings data on Tuesday, August 2nd. The medical instruments supplier reported $2.75 earnings per share for the quarter, beating analysts' consensus estimates of $2.63 by $0.12. Waters had a net margin of 24.21% and a return on equity of 203.31%. The business had revenue of $714.30 million during the quarter, compared to the consensus estimate of $706.77 million. During the same quarter in the prior year, the firm earned $2.60 EPS. The company's revenue for the quarter was up 4.8% compared to the same quarter last year. On average, sell-side analysts anticipate that Waters Co. will post 12 EPS for the current year.Analyst Ratings Changes
A number of equities analysts have commented on WAT shares. Credit Suisse Group started coverage on shares of Waters in a report on Wednesday, August 24th. They issued a "neutral" rating and a $345.00 price objective on the stock. UBS Group boosted their price objective on shares of Waters from $349.00 to $375.00 and gave the stock a "neutral" rating in a report on Thursday, August 4th. Barclays dropped their target price on shares of Waters from $375.00 to $345.00 and set an "overweight" rating for the company in a research report on Monday, September 12th. Cowen boosted their target price on shares of Waters to $378.00 in a research report on Tuesday, August 9th. Finally, Robert W. Baird boosted their target price on shares of Waters from $340.00 to $348.00 in a research report on Wednesday, August 3rd. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $348.25.
Waters Profile
(Get Rating)
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Articles
- Get a free copy of the StockNews.com research report on Waters (WAT)
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- 2 Semiconductor Stocks To Watch For Reversals
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.